[HTML][HTML] Prospect of sodium–glucose co-transporter 2 inhibitors combined with insulin for the treatment of type 2 diabetes
Y Yang, C Zhao, Y Ye, M Yu, X Qu - Frontiers in Endocrinology, 2020 - frontiersin.org
Sodium–glucose co-transporter 2 (SGLT2) inhibitors are a new family of antidiabetic drugs
that reduce blood glucose independent of insulin. In this review, we present the advantages …
that reduce blood glucose independent of insulin. In this review, we present the advantages …
[HTML][HTML] Prospect of Sodium–Glucose Co-transporter 2 Inhibitors Combined With Insulin for the Treatment of Type 2 Diabetes
Y Yang, C Zhao, Y Ye, M Yu, X Qu - Frontiers in Endocrinology, 2020 - ncbi.nlm.nih.gov
Abstract Sodium–glucose co-transporter 2 (SGLT2) inhibitors are a new family of
antidiabetic drugs that reduce blood glucose independent of insulin. In this review, we …
antidiabetic drugs that reduce blood glucose independent of insulin. In this review, we …
Prospect of Sodium-Glucose Co-transporter 2 Inhibitors Combined With Insulin for the Treatment of Type 2 Diabetes
Y Yang, C Zhao, Y Ye, M Yu… - Frontiers in …, 2020 - pubmed.ncbi.nlm.nih.gov
Sodium-glucose co-transporter 2 (SGLT2) inhibitors are a new family of antidiabetic drugs
that reduce blood glucose independent of insulin. In this review, we present the advantages …
that reduce blood glucose independent of insulin. In this review, we present the advantages …
Prospect of Sodium-Glucose Co-transporter 2 Inhibitors Combined With Insulin for the Treatment of Type 2 Diabetes.
Y Yang, C Zhao, Y Ye, M Yu, X Qu - Frontiers in Endocrinology, 2020 - europepmc.org
Abstract Sodium–glucose co-transporter 2 (SGLT2) inhibitors are a new family of
antidiabetic drugs that reduce blood glucose independent of insulin. In this review, we …
antidiabetic drugs that reduce blood glucose independent of insulin. In this review, we …